Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: BDY001
MIFTS: 39

Body Dysmorphic Disorder

Categories: Mental diseases, Neuronal diseases
Genes Variations Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Body Dysmorphic Disorder

About this section

MalaCards integrated aliases for Body Dysmorphic Disorder:

Name: Body Dysmorphic Disorder 12 74 36 15
Dysmorphophobia 12 74
Body Dysmorphic Disorders 71
Dysmorphic Syndrome 12
Body Dysmorphia 12

Classifications:

MalaCards categories:
Anatomical: Mental diseases Neuronal diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:0060163
KEGG 36 H01447
UMLS 71 C0005887
Sources

Summaries for Body Dysmorphic Disorder

About this section
KEGG : 36 Body dysmorphic disorder (BDD) is a psychiatric disorder in which individuals are preoccupied with imagined defects in their appearance, which are not noticeable or appear slight to others. It is characterized by time-consuming behaviors such as mirror gazing, comparing one's appearance with the appearance of others, excessive camouflaging to hide the defect, and seeking reassurance. Patients experience significant distress, disability, and functional impairment, often accompanied by depression and suicidality. There is some clinical and pathologic overlap between obsessive-compulsive disorder (OCD) and BDD such as obsessive thoughts and the performance of ritual behavior. Patients with BDD respond to treatment with serotonergic agents such as clomipramine or selective serotonin reuptake inhibitors (SSRIs), which suggests a dysfunction of central serotonergic neurotransmission as a possible etiological factor. A recent study suggests that cognitive-behavior therapy (CBT) was more effective than treatment with medications.

MalaCards based summary : Body Dysmorphic Disorder, also known as dysmorphophobia, is related to personality disorder and somatization disorder. An important gene associated with Body Dysmorphic Disorder is SLITRK1 (SLIT And NTRK Like Family Member 1), and among its related pathways/superpathways are Serotonergic synapse and Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics. The drugs Levetiracetam and Fluoxetine have been mentioned in the context of this disorder. Affiliated tissues include brain, skin and breast.

Disease Ontology : 12 A somatoform disorder that involves an excessive concern about and preoccupation with a perceived defect in his or her physical features (body image).

Wikipedia : 74 Body dysmorphic disorder (BDD), occasionally still called dysmorphophobia, is a mental disorder... more...

Sources

Related Diseases for Body Dysmorphic Disorder

About this section

Diseases related to Body Dysmorphic Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 304)
# Related Disease Score Top Affiliating Genes
1 personality disorder 31.1 SLC6A4 HTR2A HTR1D
2 somatization disorder 30.9 SLC6A4 HTR2A
3 hypochondriasis 30.9 SLITRK1 SLC6A4 HTR2A
4 mental depression 30.8 SLC6A4 RTN4 HTR2A
5 neurotic disorder 30.5 SLC6A4 HTR2A
6 anxiety 30.5 SLC6A4 SLC1A1 HTR2A HTR1D
7 borderline personality disorder 30.5 SLC6A4 HTR2A HTR1D
8 obsessive-compulsive disorder 30.4 SLITRK5 SLITRK1 SLC6A4 SLC1A1 HTR2A HTR1D
9 trichotillomania 30.4 SLITRK5 SLITRK1 SLC1A1 DLGAP3
10 atypical depressive disorder 30.3 SLC6A4 HTR2A
11 obsessive-compulsive personality disorder 30.2 SLITRK1 SLC6A4 HTR2A
12 substance abuse 30.2 SLC6A4 RTN4 HTR2A
13 adjustment disorder 30.2 SLC6A4 HTR2A
14 dysthymic disorder 30.2 SLC6A4 HTR2A
15 pathological gambling 30.2 SLC6A4 RTN4 HTR2A
16 psychotic disorder 30.2 SLC6A4 SLC1A1 RTN4 HTR2A
17 gilles de la tourette syndrome 30.0 SLITRK1 SLC6A4 HTR2A DLGAP3
18 alcohol use disorder 29.9 SLC6A4 RTN4 HTR2A
19 hypoparathyroidism-retardation-dysmorphism syndrome 12.5
20 hypoparathyroidism-intellectual disability-dysmorphism syndrome 12.3
21 aids dysmorphic syndrome 12.2
22 night blindness-skeletal anomalies-dysmorphism syndrome 12.0
23 genetic multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome 12.0
24 hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism syndrome 12.0
25 intellectual disability-expressive aphasia-facial dysmorphism syndrome 12.0
26 congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome 12.0
27 multiple congenital anomalies/dysmorphic syndrome-intellectual disability 12.0
28 multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome 12.0
29 birk-barel syndrome 12.0
30 genetic multiple congenital anomalies/dysmorphic syndrome 12.0
31 overgrowth-macrocephaly-facial dysmorphism syndrome 12.0
32 thin ribs-tubular bones-dysmorphism syndrome 12.0
33 short stature-deafness-neutrophil dysfunction-dysmorphism syndrome 12.0
34 genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability 12.0
35 intellectual disability-obesity-brain malformations-facial dysmorphism syndrome 12.0
36 lethal multiple congenital anomalies/dysmorphic syndrome 12.0
37 intellectual disability-muscle weakness-short stature-facial dysmorphism syndrome 12.0
38 microcephaly-short stature-intellectual disability-facial dysmorphism syndrome 12.0
39 metopic ridging-ptosis-facial dysmorphism syndrome 12.0
40 genetic lethal multiple congenital anomalies/dysmorphic syndrome 12.0
41 multiple congenital anomalies/dysmorphic syndrome 12.0
42 osteopenia-myopia-hearing loss-intellectual disability-facial dysmorphism syndrome 12.0
43 x-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism syndrome 12.0
44 obsolete: dysmorphic syndrome associated with bone anomaly 12.0
45 multiple congenital anomalies/dysmorphic syndrome without intellectual disability 12.0
46 burn-mckeown syndrome 11.8
47 mental retardation with language impairment and with or without autistic features 11.7
48 arachnodactyly - intellectual disability - dysmorphism 11.6
49 epiphyseal dysplasia hearing loss dysmorphism 11.6
50 kcnk9 imprinting syndrome 11.5

Graphical network of the top 20 diseases related to Body Dysmorphic Disorder:



Diseases related to Body Dysmorphic Disorder
Sources

Symptoms & Phenotypes for Body Dysmorphic Disorder

About this section
Sources

Drugs & Therapeutics for Body Dysmorphic Disorder

About this section

Drugs for Body Dysmorphic Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 54)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Levetiracetam Approved Phase 4 102767-28-2 441341
2
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
3
Norepinephrine Approved Phase 4 51-41-2 439260
4 Nootropic Agents Phase 4
5 Anticonvulsants Phase 4
6 Cytochrome P-450 Enzyme Inhibitors Phase 4
7 Cytochrome P-450 CYP2D6 Inhibitors Phase 4
8 Serotonin Agents Phase 4
9 Neurotransmitter Agents Phase 4
10 Serotonin Uptake Inhibitors Phase 4
11 Venlafaxine Hydrochloride Phase 4
12 Antidepressive Agents Phase 4
13 Psychotropic Drugs Phase 4
14 Serotonin and Noradrenaline Reuptake Inhibitors Phase 4
15
Serotonin Investigational, Nutraceutical Phase 4 50-67-9 5202
16
Citalopram Approved Phase 3 59729-33-8 2771
17 Antiparkinson Agents Phase 3
18 Cholinergic Agents Phase 3
19 Autonomic Agents Phase 3
20 Muscarinic Antagonists Phase 3
21 Cholinergic Antagonists Phase 3
22 Parasympatholytics Phase 3
23
Oxytocin Approved, Vet_approved Phase 2 50-56-6 439302 53477758
24
Milk thistle Approved, Experimental, Investigational Phase 2 65666-07-1
25
Lactitol Investigational Phase 2 585-86-4, 585-88-6 493591
26 Oxytocics Phase 2
27 Hormones Phase 2
28 Antioxidants Phase 2
29 Protective Agents Phase 2
30 silymarin Phase 2
31
Cycloserine Approved Early Phase 1 68-41-7 401 6234
32
Dopamine Approved 51-61-6, 62-31-7 681
33
Memantine Approved, Investigational 19982-08-2 4054
34
Cocaine Approved, Illicit 50-36-2 5760 446220
35
Diprenorphine Illicit, Vet_approved 14357-78-9
36 Anti-Infective Agents Early Phase 1
37 Renal Agents Early Phase 1
38 Antitubercular Agents Early Phase 1
39 Antibiotics, Antitubercular Early Phase 1
40 Anti-Bacterial Agents Early Phase 1
41 Anti-Infective Agents, Urinary Early Phase 1
42 Antimetabolites Early Phase 1
43 Dopamine Agents
44 Excitatory Amino Acids
45 Excitatory Amino Acid Antagonists
46 Narcotics
47 Analgesics, Opioid
48 Central Nervous System Depressants
49 Analgesics
50 Narcotic Antagonists

Interventional clinical trials:

(show all 42)
# Name Status NCT ID Phase Drugs
1 Open-Label Study of Levetiracetam in Body Dysmorphic Disorder Completed NCT00265109 Phase 4 Levetiracetam
2 Fluoxetine in Pediatric Body Dysmorphic Disorder Completed NCT00245635 Phase 4 Fluoxetine;Placebo
3 A Controlled Trial of Cognitive-Behavioral Therapy as an Adjunct to Serotonin Reuptake Inhibitors in Body Dysmorphic Disorder Terminated NCT00211809 Phase 4 Venlafaxine
4 Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder Completed NCT00149799 Phase 3 Escitalopram;Placebo
5 Crooked Mirror Externalization Therapy for Body Dysmorphic Disorder Unknown status NCT01316627 Phase 2
6 Effect of Intranasal Oxytocin on Social Cognition Completed NCT02671266 Phase 2 Oxytocin;Placebo
7 Silymarin Treatment of Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled, Cross-Over Study Recruiting NCT02843451 Phase 2 Milk Thistle;Placebo
8 Quality of Life and Body Image in Women Underwent Thighplasty Completed NCT01453231 Phase 1
9 CBT Versus Supportive Psychotherapy for Body Dysmorphic Disorder Unknown status NCT01453439
10 Body Image Disorder in Anorexia Nervosa and Virtual Reality Unknown status NCT03118921
11 Attentional Bias in Body Dysmorphic Disorder Completed NCT01398904
12 Internet-based Cognitive Behavior Therapy for Body Dysmorphic Disorder: A Pilot Study Completed NCT01850433
13 Internet Delivered Cognitive Behavior Therapy for Body Dysmorphic Disorder - a Randomized Controlled Trial Completed NCT02010619
14 A Randomized, Double-blind, Placebo-controlled Trial of D-cycloserine Augmentation of Behavior Therapy for Body Dysmorphic Disorder Completed NCT00842309 Early Phase 1 d-cycloserine;Placebo
15 Antiglutamatergic Treatment of Bulimia Nervosa and Body Dysmorphic Disorder: An Open-Label Trial of Memantine Completed NCT01038128 Memantine
16 An Open Trial of Cognitive-Behavioral Therapy (CBT) for Pediatric Body Dysmorphic Disorder (BDD) Completed NCT01002326
17 Evaluation of an Internet-Based Treatment for Body Dysmorphic Disorder Completed NCT02635152
18 A Virtual Reality Study of Cognitive Biases in Body Dysmorphic Disorder Completed NCT03773549
19 Development of a Cognitive Behavioral Mobile App for Body Dysmorphic Disorder, and Tests of Feasibility, Acceptability, and Preliminary Efficacy Completed NCT03221738
20 A Randomized Waitlist Controlled Treatment Trial Investigating CBT for Body Dysmorphic Disorder Completed NCT00106223
21 Cerebral Metabolic Correlates of Treatment Response to Escitalopram in Body Dysmorphic Disorder Completed NCT01398865
22 Efficacy of Cognitive Behaviour Therapy -v- Anxiety Management for Body Dysmorphic Disorder: a Randomised Controlled Trial Completed NCT00871143
23 Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study Completed NCT02524301 Positron Emission Tomography using [11C]diprenorphine
24 An Interactive Internet-based Program for Prevention of Eating Disorders on a Broad Basis Completed NCT02567890
25 Body Image in Patients With Rheumatoid Arthritis Completed NCT00832910
26 Impairment of Central Coherence in Restrictive Anorexia Nervosa: Single-center and Case-control Study Completed NCT02381639
27 Effectiveness of Dance on Patients With Fibromyalgia Completed NCT00961805
28 Studies of Cortical Excitability in Obsessive-Compulsive Disorder, Related Disorder and Healthy Volunteers Using Paired-Pulse Transcranial Magnetic Stimulation Completed NCT00029068
29 Prevention of Body Image Disorder by Nurse Intervention on the Patient and Family Prior to Breast and Colon Surgery Completed NCT03726801
30 Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine: a Naturalistic, Prospective, Multicentric Observational Study of 6 Months Follow-up Completed NCT00952757
31 Smartphone Cognitive Behavioral Therapy for Body Dysmorphic Disorder: A Randomized, Waitlist-control Trial Recruiting NCT04034693
32 Contribution of a Virtual Reality Program in the Treatment of Dysmorphophobia for Adolescent Female With Anorexia Nervosa Recruiting NCT03426930
33 White Light Scanning to Aid Body Contouring: A Pilot Project Recruiting NCT01093950
34 Brain Correlates of Self-Focused Processing as a Biomarker of Treatment Response Recruiting NCT02808702
35 Investigation Into the Impact of Exposure to Images of the Idealised Physique on Body Satisfaction, Dieting Intentions and Mood in Men. Recruiting NCT03991351
36 Descriptive Study of Buccodental Manifestations in a Group of Acromegalic Patients (AcroDent) Followed in the Endocrinology/Diabetology Service in the CHU of Clermont-Ferrand Recruiting NCT03401008
37 Feasibility Pilot Study of Internet-based CBT for Body Dysmorphic Disorder With Global Recruitment Active, not recruiting NCT03517384
38 A Mobile-App Training to Reduce Body Image Disorder Symptoms and Associated Psychological Features in Female University Students: A Randomized Controlled Pilot Study With Crossover Design Active, not recruiting NCT04103606
39 Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals in a General Hospital Setting Active, not recruiting NCT01075672
40 Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorder in Female Adolescents With Anorexia Nervosa: a Randomized, Controlled Superiority Study Not yet recruiting NCT04107870
41 Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders Not yet recruiting NCT03918577
42 Smartphone Cognitive Behavioral Therapy for Body Dysmorphic Disorder: A Randomized, Waitlist-control Trial Withdrawn NCT03673046

Search NIH Clinical Center for Body Dysmorphic Disorder

Sources

Genetic Tests for Body Dysmorphic Disorder

About this section
Sources

Anatomical Context for Body Dysmorphic Disorder

About this section

MalaCards organs/tissues related to Body Dysmorphic Disorder:

40
Brain, Skin, Breast, Bone, Testes, Eye, Heart
Sources

Publications for Body Dysmorphic Disorder

About this section

Articles related to Body Dysmorphic Disorder:

(show top 50) (show all 1177)
# Title Authors PMID Year
1
Body dysmorphic disorder in patients with acne: a multicentre study. 61
31515838 2020
2
A network perspective on body dysmorphic disorder and major depressive disorder. 61
31733461 2020
3
Electroconvulsive therapy in an adolescent with bipolar disorder, substance use, and body dysmorphic disorder comorbidity: case report. 61
31642388 2020
4
Delusional themes in Body Dysmorphic Disorder (BDD): Comparisons with psychotic disorders and non-clinical Controls. 61
31785950 2020
5
Body Dysmorphic Disorder in Plastic Surgery: What to Know When Facing a Patient Requesting a Labiaplasty. 61
31985695 2020
6
Development and Pilot Testing of a Cognitive-Behavioral Therapy Digital Service for Body Dysmorphic Disorder. 61
32005333 2020
7
Introduction: Rare and unusual andrologic syndromes that clinicians should be aware of. 61
32033721 2020
8
Effects of safety behavior fading on appearance concerns and related symptoms. 61
31670542 2020
9
Correlation of the Standardized Cosmesis and Health Nasal Outcomes Survey With Psychiatric Screening Tools. 61
31917417 2020
10
A Comparison Between Hyaluronic Acid and Polylactic Acid Filler Injections for Temporary Penile Augmentation in Patients with Small Penis Syndrome: A Multicenter, Patient/Evaluator-Blind, Comparative, Randomized Trial. 61
31735613 2020
11
Elective Female Genital Cosmetic Surgery: ACOG Committee Opinion Summary, Number 795. 61
31856120 2020
12
Elective Female Genital Cosmetic Surgery: ACOG Committee Opinion, Number 795. 61
31856125 2020
13
Genital manifestations of body dysmorphic disorder in men: a review. 61
32033717 2020
14
Event-related EEG oscillations in Body Dysmorphic Disorder. 61
31995842 2020
15
Prevalence and characteristics of body dysmorphic disorder in Arab dermatology patients. 61
31915798 2020
16
Body dysmorphic disorder and major depressive episode have comorbidity-independent associations with suicidality in an acute psychiatric setting. 61
31450136 2019
17
Influencing Factors of Social Anxiety Disorder and Body Dysmorphic Disorder in a Nonclinical Brazilian Population. 61
30388392 2019
18
The Multidimensional Youth Body Dysmorphic Inventory: Development and Preliminary Validation. 61
31065951 2019
19
Body image, cosmetic surgery, and minimally invasive treatments. 61
30704847 2019
20
Dysmorphic concern and behavioural impairment related to body image in adolescents. 61
31875990 2019
21
Serum oxytocin levels are elevated in body dysmorphic disorder and related to severity of psychopathology. 61
31862613 2019
22
Body Dysmorphic Disorder in Plastic Surgery: What to Know when Facing a Patient Requesting a Labiaplasty. 61
31834285 2019
23
Motives for Illicit Drug Use Among Individuals With Body Dysmorphic Disorder. 61
31821219 2019
24
Prevalence and impact of insomnia in children and adolescents with body dysmorphic disorder undergoing multimodal specialist treatment. 61
31760510 2019
25
Major Motivators and Sociodemographic Features of Women Undergoing Labiaplasty. 61
30535095 2019
26
Body dysmorphic disorder and facial aesthetic treatments in dental practice. 61
31758136 2019
27
Gazing rituals in body dysmorphic disorder. 61
31877406 2019
28
Empirically defining treatment response and remission in body dysmorphic disorder. 61
31662124 2019
29
A Novel Mobile Tool (Somatomap) to Assess Body Image Perception Pilot Tested With Fashion Models and Nonmodels: Cross-Sectional Study. 61
31469647 2019
30
Association of Body Dysmorphic Disorder with Leptin Levels in Patients with Normal Weight Undergoing Liposuction: A Matched Case Study. 61
31772903 2019
31
Magnitude and determinants of body dysmorphic disorder among female students in Saudi public secondary schools. 61
31728142 2019
32
Sociocultural Attitudes towards Appearance, Self-Esteem and Symptoms of Body-Dysmorphic Disorders among Young Adults. 61
31683731 2019
33
Disturbed Eating and Body Dysmorphic Symptoms in a Young Adult Sample Are Separable Constructs That Each Show a Mixture of Distributions. 61
31609131 2019
34
Experimental induction of self-focused attention via mirror gazing: Effects on body image, appraisals, body-focused shame, and self-esteem. 61
31336262 2019
35
Personality as a Predictor of Treatment Response to Escitalopram in Adults With Body Dysmorphic Disorder. 61
31505519 2019
36
Intranasal oxytocin alters amygdala-temporal resting-state functional connectivity in body dysmorphic disorder: A double-blind placebo-controlled randomized trial. 61
31146138 2019
37
The color of skin: psychiatric ramifications. 61
31896401 2019
38
Impaired Recognition of Negative Facial Emotions in Body Dysmorphic Disorder. 61
31099324 2019
39
Body Dysmorphic Disorder: Is There an "Ideal" Strategy? 61
31011755 2019
40
People allergic to me and body dysmorphic disorder. 61
31325759 2019
41
High Prevalence of Body Dysmorphic Disorder and Moderate to Severe Appearance-Related Obsessive-Compulsive Symptoms Among Rhinoplasty Candidates. 61
30607575 2019
42
Invited Response on: Body Dysmorphic Disorder: There is an "Ideal" Strategy? 61
31139915 2019
43
Modeling subjective belief states in computational psychiatry: interoceptive inference as a candidate framework. 61
31230144 2019
44
Is perfectionism a risk factor for adolescent body dysmorphic symptoms? Evidence for a prospective association. 61
31534902 2019
45
Predictors of Response to Cognitive-Behavioral Therapy for Body Dysmorphic Disorder. 61
31208692 2019
46
Low prevalence of body dysmorphic disorder in specific public and private practices in Australia. 61
30979400 2019
47
Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatments. 61
31038370 2019
48
[Labiaplasty: Motivations and post-surgery satisfaction]. 61
31003016 2019
49
French translation, cultural adaptation and validation of the BDDQ-AS for rhinoplasty patients. 61
31092284 2019
50
[The Body Dysmorphic Disorder in Plastic Surgery - A Systematic Review of Screening Methods]. 61
31618775 2019
Sources

Variations for Body Dysmorphic Disorder

About this section

Copy number variations for Body Dysmorphic Disorder from CNVD:

7
# CNVD ID Chromosome Start End Type Gene Symbol CNVD Disease
1 63474 12 119100000 132349534 Deletion FBXW8 dysmorphic
2 63477 12 119100000 132349534 Deletion FZD10 dysmorphic
3 63480 12 119100000 132349534 Deletion NCOR2 dysmorphic
4 63483 12 119100000 132349534 Deletion P2RX2 dysmorphic
5 63486 12 119100000 132349534 Deletion RAN dysmorphic
6 63489 12 119100000 132349534 Deletion STX2 dysmorphic
7 63492 12 119100000 132349534 Deletion TBX3 dysmorphic
8 63495 12 119100000 132349534 Deletion TESC dysmorphic
9 63498 12 119100000 132349534 Deletion ULK1 dysmorphic
Sources

Expression for Body Dysmorphic Disorder

About this section
Search GEO for disease gene expression data for Body Dysmorphic Disorder.
Sources

Pathways for Body Dysmorphic Disorder

About this section

Pathways related to Body Dysmorphic Disorder according to KEGG:

36
# Name Kegg Source Accession
1 Serotonergic synapse hsa04726

Pathways related to Body Dysmorphic Disorder according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Serotonergic synapse 36
11.19 SLC6A4 HTR2A HTR1D
2
Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics 60
10.25 SLC6A4 HTR2A HTR1D
Sources

GO Terms for Body Dysmorphic Disorder

About this section

Cellular components related to Body Dysmorphic Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 plasma membrane GO:0005886 9.93 SLITRK5 SLITRK1 SLC6A4 SLC1A1 RTN4 PHACTR2
2 glutamatergic synapse GO:0098978 9.56 SLITRK1 HTR2A GPC6 DLGAP3
3 cell junction GO:0030054 9.43 SLITRK1 SLC6A4 SLC1A1 RTN4 NUDT9 DLGAP3
4 synapse GO:0045202 9.23 SLITRK5 SLITRK1 SLC6A4 SLC1A1 HTR1D GPC6

Biological processes related to Body Dysmorphic Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 glycosaminoglycan catabolic process GO:0006027 9.32 GPC6 GPC1
2 synaptic membrane adhesion GO:0099560 9.26 SLITRK1 GPC6
3 chemical synaptic transmission GO:0007268 9.26 SLITRK5 SLC1A1 HTR2A HTR1D
4 vasoconstriction GO:0042310 9.16 SLC6A4 HTR1D
5 regulation of protein localization to membrane GO:1905475 8.62 GPC6 GPC1

Molecular functions related to Body Dysmorphic Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 serotonin binding GO:0051378 8.62 SLC6A4 HTR2A
Sources

Sources for Body Dysmorphic Disorder

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....